Disclosed are chimeric HPV L1 proteins and virus like particles comprising
the same which are capable of generating high titer neutralizing antibody responses
against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs
are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing
papillomavirus infection.
